| ISIN | LU1045226963 |
|---|---|
| Valor Number | 23884622 |
| Bloomberg Global ID | |
| Fund Name | Cadmos-Swiss Equitues A |
| Fund Provider |
de Pury Pictet Turrettini & Cie S.A.
Genève 11, Switzerland Phone: +41 22 317 00 30 E-Mail: contact@ppt.ch Web: www.ppt.ch |
| Fund Provider | de Pury Pictet Turrettini & Cie S.A. |
| Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
| Distributor(s) |
Pictet Asset Management SA. Genève 73 Phone: +41 58 323 30 00 |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 196.56 CHF | 09.12.2025 |
|---|---|---|
| Previous Price * | 196.85 CHF | 08.12.2025 |
| 52 Week High * | 202.95 CHF | 17.02.2025 |
| 52 Week Low * | 163.73 CHF | 09.04.2025 |
| NAV * | 196.56 CHF | 09.12.2025 |
| Issue Price * | 196.56 CHF | 09.12.2025 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 61,743,343 | |
| Unit/Share Assets *** | 27,003,470 | |
| Trading Information SIX | ||
| YTD Performance | +6.47% |
31.12.2024 - 09.12.2025
31.12.2024 09.12.2025 |
|---|---|---|
| 1 month | +2.10% |
10.11.2025 - 09.12.2025
10.11.2025 09.12.2025 |
| 3 months | +0.26% |
09.09.2025 - 09.12.2025
09.09.2025 09.12.2025 |
| 6 months | -0.06% |
09.06.2025 - 09.12.2025
09.06.2025 09.12.2025 |
| 1 year | +4.57% |
09.12.2024 - 09.12.2025
09.12.2024 09.12.2025 |
| 2 years | +12.69% |
11.12.2023 - 09.12.2025
11.12.2023 09.12.2025 |
| 3 years | +19.11% |
09.12.2022 - 09.12.2025
09.12.2022 09.12.2025 |
| 5 years | +18.11% |
09.12.2020 - 09.12.2025
09.12.2020 09.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 7.41% | |
|---|---|---|
| Swiss Life Holding AG | 6.15% | |
| ABB Ltd | 5.09% | |
| Zurich Insurance Group AG | 4.85% | |
| Swissquote Group Holding SA | 4.47% | |
| Novartis AG Registered Shares | 4.38% | |
| Belimo Holding AG | 4.33% | |
| Lonza Group Ltd | 4.24% | |
| Compagnie Financiere Richemont SA Class A | 4.14% | |
| Givaudan SA | 4.00% | |
| Last data update | 31.08.2025 | |
| TER *** | 1.976% |
|---|---|
| TER date *** | 31.08.2025 |
| Performance Fee *** | 20.00% |
| PTR | |
| Max. Management Fee *** | 1.55% |
| Ongoing Charges *** | 1.98% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |